Cargando…
The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions
BACKGROUND: Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed t...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556052/ https://www.ncbi.nlm.nih.gov/pubmed/33082889 http://dx.doi.org/10.1155/2020/1283590 |
_version_ | 1783594150922289152 |
---|---|
author | Varsamas, Charalampos Kalkanis, Alexandros Gourgoulianis, Konstantinos I. Malli, Foteini |
author_facet | Varsamas, Charalampos Kalkanis, Alexandros Gourgoulianis, Konstantinos I. Malli, Foteini |
author_sort | Varsamas, Charalampos |
collection | PubMed |
description | BACKGROUND: Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. METHODS: All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. RESULTS: Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p < 0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p < 0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p < 0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p < 0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE. |
format | Online Article Text |
id | pubmed-7556052 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Hindawi |
record_format | MEDLINE/PubMed |
spelling | pubmed-75560522020-10-19 The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions Varsamas, Charalampos Kalkanis, Alexandros Gourgoulianis, Konstantinos I. Malli, Foteini Can Respir J Research Article BACKGROUND: Thoracic ultrasound is an essential tool in the daily clinical care of pleural effusions and especially parapneumonic pleural effusions (PPEs), in terms of diagnosis, management, and follow-up. Hypoechogenicity index (HI) is a quantitative marker of pleural fluid echogenicity. We aimed to examine associations of HI with pleural inflammation in patients with PPE. METHODS: All patients included underwent a thoracic ultrasound with HI determination at the first day of their admission for a PPE. Thoracentesis was performed in all patients. Demographics, laboratory measurements, and clinical data were collected prospectively and recorded in all subjects. RESULTS: Twenty-four patients with PPE were included in the study. HI was statistically significantly correlated with intensity of inflammation as suggested by pleural fluid LDH (p < 0.001, r = −0.831), pleural fluid glucose (p=0.022, r = 0.474), and pleural fluid pH (p < 0.001, r = 0.811). HI was correlated with ADA levels (p=0.005, r = −0.552). We observed a statistically significant correlation of HI with pleural fluid total cell number (p < 0.001, r = −0.657) and polymorphonuclears percentage (p=0.02, r = −0.590), as well as days to afebrile (p=0.046, r = −0.411), duration of chest tube placement (p < 0.001, r = −0.806), and days of hospitalization (p=0.013, r = −0.501). Discussion. HI presents a fast, easily applicable, objective, and quantitative marker of pleural inflammation that reliably reflects the intensity of pleural inflammation and could potentially guide therapeutic management of PPE. Hindawi 2020-10-05 /pmc/articles/PMC7556052/ /pubmed/33082889 http://dx.doi.org/10.1155/2020/1283590 Text en Copyright © 2020 Charalampos Varsamas et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Varsamas, Charalampos Kalkanis, Alexandros Gourgoulianis, Konstantinos I. Malli, Foteini The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_full | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_fullStr | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_full_unstemmed | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_short | The Use of a Novel Quantitative Marker of Echogenicity of Pleural Fluid in Parapneumonic Pleural Effusions |
title_sort | use of a novel quantitative marker of echogenicity of pleural fluid in parapneumonic pleural effusions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556052/ https://www.ncbi.nlm.nih.gov/pubmed/33082889 http://dx.doi.org/10.1155/2020/1283590 |
work_keys_str_mv | AT varsamascharalampos theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT kalkanisalexandros theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT gourgoulianiskonstantinosi theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT mallifoteini theuseofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT varsamascharalampos useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT kalkanisalexandros useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT gourgoulianiskonstantinosi useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions AT mallifoteini useofanovelquantitativemarkerofechogenicityofpleuralfluidinparapneumonicpleuraleffusions |